Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Taylor

Showing results (121-130 of 246) with videos related to

Pageof 25
Sort By:
JMIR Research Protocols|July 18, 2018
The Development of Complex Digital Health Solutions: Formative Evaluation Combining Different MethodologiesAnne Lee, Marianne Sandvei, Hans Christian Asmussen, et al.
Annals of the Rheumatic Diseases|July 31, 2014
OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapyPeter C Taylor, Mark C Genovese, Mike Greenwood, et al.
Frontiers in Immunology|October 16, 2018
The IL-20 Cytokine Family in Rheumatoid Arthritis and SpondyloarthritisTue W Kragstrup, Thomas Andersen, Line D Heftdal, et al.
Rheumatology International|March 23, 2018
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritisBruno Fautrel, Rieke Alten, Bruce Kirkham, et al.
Rheumatology and Therapy|December 17, 2024
Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational StudyPeter C Taylor, Walid Fakhouri, Samuel Ogwu, et al.
Rheumatology and Therapy|June 23, 2023
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation AnalysisLars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, et al.
Advances in Therapy|June 22, 2023
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19Thomas Bieber, Eugen Feist, Alan D Irvine, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
STAT3 phosphorylation in the rheumatoid arthritis immunological synapseHila Novak Kotzer, Jesusa Capera, Ashwin Jainarayanan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancerMatthew R Watts, Peter C Taylor, Vitali Sintchenko, et al.
International Journal of Rheumatic Diseases|May 17, 2023
Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trialsYoshiya Tanaka, Tsutomu Takeuchi, Derek Haaland, et al.
Pageof 25

Showing results (121-130 of 246) with videos related to

Sort By:
Pageof 25
JMIR Research Protocols|July 18, 2018
The Development of Complex Digital Health Solutions: Formative Evaluation Combining Different MethodologiesAnne Lee, Marianne Sandvei, Hans Christian Asmussen, et al.
Annals of the Rheumatic Diseases|July 31, 2014
OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapyPeter C Taylor, Mark C Genovese, Mike Greenwood, et al.
Frontiers in Immunology|October 16, 2018
The IL-20 Cytokine Family in Rheumatoid Arthritis and SpondyloarthritisTue W Kragstrup, Thomas Andersen, Line D Heftdal, et al.
Rheumatology International|March 23, 2018
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritisBruno Fautrel, Rieke Alten, Bruce Kirkham, et al.
Rheumatology and Therapy|December 17, 2024
Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational StudyPeter C Taylor, Walid Fakhouri, Samuel Ogwu, et al.
Rheumatology and Therapy|June 23, 2023
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation AnalysisLars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, et al.
Advances in Therapy|June 22, 2023
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19Thomas Bieber, Eugen Feist, Alan D Irvine, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
STAT3 phosphorylation in the rheumatoid arthritis immunological synapseHila Novak Kotzer, Jesusa Capera, Ashwin Jainarayanan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancerMatthew R Watts, Peter C Taylor, Vitali Sintchenko, et al.
International Journal of Rheumatic Diseases|May 17, 2023
Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trialsYoshiya Tanaka, Tsutomu Takeuchi, Derek Haaland, et al.
Pageof 25